Testing effectiveness (Phase 2)UnknownNCT04850664
What this trial is testing
Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder
Who this might be right for
Opioid Use Disorder, ModerateOpioid Use Disorder, SevereWithdrawal Symptoms+2 more
Evon Medics LLC 190